Health In Tech, Inc. 8-K

What Happened
Health In Tech, Inc. announced that Dustin Plantholt left his role as Chief AI & Marketing Officer effective April 30, 2026, after providing formal notice on April 27, 2026. The company says the departure was part of a business transition and not due to any disagreement with the company. Following his exit, HITChain Inc. (a Health In Tech subsidiary) and Plantholt’s company, Plantholt Advisory Group LLC, entered a Consulting Agreement dated May 1, 2026.

Key Details

• Dustin Plantholt’s departure from the officer role was effective April 30, 2026; notice was given April 27, 2026.
• HITChain (subsidiary) retained Plantholt’s firm under a Consulting Agreement dated May 1, 2026; either party can terminate with 10 days’ written notice.
• Compensation under the Consulting Agreement includes monthly fees plus a Restricted Stock Award of 500,000 shares of HITChain common stock.
• The 500,000 restricted shares vest in equal monthly installments over 12 months, contingent on the consultant’s continued service.

Why It Matters
This filing signals a leadership change in Health In Tech’s AI and marketing function while maintaining a continuing relationship with the departing officer through a consulting deal. Investors should note the equity award is in the HITChain subsidiary (not necessarily Health In Tech common stock) and that the vesting is tied to ongoing services over the next year. Monitor future disclosures for any operational or financial effects, such as changes in marketing or AI initiatives or additional details on HITChain equity.